ORFADIN (nitisinone) is used for the treatment of patients with Kidney Cancer

ORFADIN is a 4-hydroxyphenylpyruvate dioxygenase inhibitor indicated for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.

ORFADIN (nitisinone) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ORFADIN (nitisinone) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the medicine and its cost price in India.

The order for ORFADIN (nitisinone) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Nitisinone is used to treat hereditary tyrosinemia type 1 (HT-1) in patients from all ages, in combination with dietary restriction of tyrosine and phenylalanine.

ORFADIN® (nitisinone) capsules, for oral use. ORFADIN® (nitisinone) oral suspension. Initial U.S. Approval: 2002

Generic Name: nitisinone

Capsules: 2 mg, 5 mg, 10 mg, 20 mg. (3)
Oral suspension: 4 mg/mL

Orfadin (nitisinone)

ORFADIN® (nitisinone) capsules, for oral use is available.

Get In Touch

ORFADIN (nitisinone) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ORFADIN (nitisinone) on prescription and Import License in Patient's Name only.

For overseas patients, ORFADIN (nitisinone) can be made available in Send your enquiry to find ORFADIN (nitisinone) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for ORFADIN (nitisinone).

FDA Approves New Generic for Rare HT-1 Disorder For More Details

FDA approves ORFADIN® (nitisinone) Oral Suspension For More Details

Channel Partner In India

Delhi Office

60/4, T&T House. Yusuf Sarai,
New Delhi:110016

Bangalore Office

#308, Raheja Chambers, 12,
Museum Road, Bangalore 560 001

Kolkata Office

1/A R.G Kar Road, Shayambazar,
Kolkata 700004

Lucknow Office

203-A, 2nd Floor, Tower -11, Felix
Square, IBB-2, Sushant Golf city, Lucknow 226030